A Study of OLR in First-line Treatment of Mantle Cell Lymphoma
Clinical trial NCT05076097 · UNKNOWN
Trial details
- NCT number
- NCT05076097
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-30
- Primary completion
- 2022-10-15
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.